PHR:NYE-Phreesia Inc (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 25.61

Change

+0.99 (+4.02)%

Market Cap

N/A

Volume

0.28M

Analyst Target

USD 30.11
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-30 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
SOLV Solventum Corp.

N/A

USD 10.78B
DOCS Doximity Inc

N/A

USD 6.81B
WEAV Weave Communications Inc

N/A

USD 0.81B
MPLN MultiPlan Corporation

N/A

USD 0.16B
AMWL American Well Corp

N/A

USD 0.12B
OWLT Owlet Inc

N/A

USD 0.05B
TDOC Teladoc Inc

N/A

N/A
FOXO FOXO Technologies Inc.

N/A

N/A
EVH Evolent Health Inc

N/A

N/A
VEEV Veeva Systems Inc Class A

N/A

N/A

ETFs Containing PHR

W311:F HAN-GINS Indxx Healthcare.. 1.17 % 0.00 %

N/A

USD 0.02B
WELL:PA HAN-GINS Indxx Healthcare.. 1.17 % 0.00 %

N/A

N/A
WELL:SW HAN-GINS Indxx Healthcare.. 1.17 % 0.00 %

N/A

N/A
W311:XETRA HAN-GINS Indxx Healthcare.. 0.00 % 0.00 %

N/A

USD 0.02B

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.63% 100% F 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.63% 100% F 63% D
Trailing 12 Months  
Capital Gain -19.69% 60% D- 12% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -19.69% 60% D- 11% F
Trailing 5 Years  
Capital Gain -6.60% 50% F 39% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -6.60% 50% F 25% F
Average Annual (5 Year Horizon)  
Capital Gain 13.97% 82% B 78% C+
Dividend Return 13.97% 82% B 74% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 68.00% 45% F 11% F
Risk Adjusted Return 20.55% 64% D 43% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector